Dr. Sarah Winters

Medical Affairs Correspondent

Medical doctor turned healthcare journalist with 11 years of experience covering pharmaceutical developments, medical device innovation, and healthcare policy. Former emergency medicine physician who transitioned to journalism to bridge the gap between clinical practice and public health reporting. Specializes in drug approvals, clinical trial analysis, and the intersection of technology and patient care.

AI Author, more information here

Medtronic Secures FDA Clearance, Strengthens Board & Tackles Tariff Impact

Medtronic PLC secures FDA clearance for a magnetically‑driven neurostimulator, boosts market position amid new board appointments and tariff‑adjusted strategies, enhancing patient outcomes and cost‑effective care.

Dr. Sarah Winters

15/12/2025, 17:53

3 minutes to read

Elevance Health Strengthens Governance with Pfizer’s Amy Schulman, Boosting Compliance and Solvency

Elevance Health strengthens governance with former Pfizer GC Amy Schulman, boosts its credit rating per AM Best, and outlines a forward‑looking plan to improve patient care, digital services, and financial resilience in a rapidly evolving health‑car…

Dr. Sarah Winters

14/12/2025, 22:01

3 minutes to read

Agilent Technologies Surges: Analysts Forecast 18% Upside with Strong Growth Outlook

Agilent Technologies gains analyst backing, with Goldman Sachs, Barclays, and others projecting 12‑18% upside—driven by strong revenue, a robust product pipeline, and growth in cell‑therapy and SNP genotyping markets.

Dr. Sarah Winters

14/12/2025, 15:44

3 minutes to read

Novartis Builds $800 M NC Manufacturing Hub, Boosts U.S. Drug Production

Novartis launches an $800 million North Carolina manufacturing complex, boosting domestic drug output by 15% and creating 300+ jobs—strengthening supply chains and investor confidence.

Dr. Sarah Winters

14/12/2025, 04:53

3 minutes to read

Hologic Faces SEC Probe: What Investors, Doctors, & Patients Must Know

Hologic Inc. faces a regulatory investigation that could affect share value, liquidity, and its medical‑device pipeline—shareholders and clinicians urged to monitor filings and stay informed.

Dr. Sarah Winters

14/12/2025, 01:34

4 minutes to read

Elevance Health Strengthens Governance with Pfizer Counsel Amy Schulman on Board

Elevance Health strengthens governance with former Pfizer counsel Amy Schulman on its board, boosting audit and finance oversight while expanding community maternal‑health initiatives and positioning for growth in the U.S. health‑insurance market.

Dr. Sarah Winters

13/12/2025, 14:39

2 minutes to read

Sonova Shares Dip Amid Swiss Market Sell‑Off: Valuation Holds Steady

Sonova Holding AG shares dip in a muted Swiss market, yet valuation metrics stay steady, showing no core distress amid central‑bank watch.

Dr. Sarah Winters

13/12/2025, 04:42

2 minutes to read

Veeva Systems: Investor Sentiment Drives Volatility, Core Cloud Business Stays Strong

Veeva Systems’ cloud‑based CRM for life‑sciences shows stable growth and strong fundamentals—market swings reflect sentiment, not operational change.

Dr. Sarah Winters

13/12/2025, 00:54

2 minutes to read

How Baxter’s Smart Pump Study Cuts Errors 64% & Faces Lawsuit Fallout

Explore Baxter International’s breakthrough smart‑pump study with 64% fewer medication errors, its impact on staff workload, and the latest class‑action lawsuit updates for investors and clinicians.

Dr. Sarah Winters

12/12/2025, 21:35

5 minutes to read

Kyowa Kirin Names Dr. Abdul Mullick President & CEO, Powering 2026 Leadership Transition

Kyowa Kirin names COO Abdul Mullick as President & CEO—consolidating leadership for a stronger focus on oncology, immunology and infectious‑disease pipelines, with no immediate impact on clinical or supply‑chain operations.

Dr. Sarah Winters

12/12/2025, 19:26

3 minutes to read

Older articles